BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171021
DTEND;VALUE=DATE:20180102
DTSTAMP:20260729T155143
CREATED:20171021T172142Z
LAST-MODIFIED:20171021T172142Z
UID:19266-1508544000-1514851199@ces.b2sg.org
SUMMARY:Clinical Leader - Cancer Precision Medicine
DESCRIPTION:The UNC Lineberger Comprehensive Cancer Center and The University of North Carolina School of Medicine seek an exceptional physician scientist to lead our efforts in Cancer Precision Medicine. Over the past decade\, UNC Lineberger emerged as a leader in the NCI TCGA effort. We have developed an infrastructure for sequencing\, bioinformatic analyses\, molecular pathology\, and their application to patient care through a molecular tumor board. We now search for a translational scientist to head the clinical aspects of an expanding program. We are currently developing novel CLIA assays as well as methodologies to perform genomic analysis to identify somatic and germline mutations\, evaluate transcriptome expression using RNA-sequencing\, and characterize immune repertoires using next generation sequencing. We have developed robust applications for data analysis and anticipate that the person leading this group will utilize these other tools they develop to enhance personalized care for cancer patients and prospective clinical trials. The position is tenure track and open to those at all ranks. Applicants should provide evidence of a strong record of clinical\, translational or basic approaches to broad areas of genetics\, genomics\, gene expression\, epigenetics\, proteomics\, tumor immunology\, and/or precision early cancer detection and prevention. Applications will be reviewed by search committee chair Chuck Perou\, PhD and the committee beginning January 1\, 2018 and until the position is filled.  
URL:https://ces.b2sg.org/event/unc-clinical-leader-oct17/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
END:VCALENDAR